Global Market Watch:
The global PCR market is projected to reach around US$27.4 billion by 2015, with a Compounded Annual Growth Rate (CAGR) of 13.9% for the analysis period, 2009-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$10.7 billion by end-2010. Europe and Asia-Pacific together account for more than 50% of the global market share. Interestingly, Latin America is seen as the fastest growing market with a CAGR of 14.8%, to worth around US$1.3 billion in 2015.
Based on the classification by products/tools, PCR Reagents are expected to be fastest growing market with a CAGR of 14.6%. PCR Consumables and PCR Machines are expected grow with a CAGR of 14.2% and 13.1% respectively.
Report Focus:
The report “Polymerase Chain Reaction (PCR): Products/Tools – A Global Market Watch, 2009-2015†reviews the latest PCR market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:
Emerging market trends
Advancements in the technological space
Market demand of the segments (by-region)
Key growth areas and market size
Key competitor’s Edge
The analysis primarily deals with major PCR product/tools market. Further, the subdivided categories include:
PCR Product/Tools
PCR Machines
PCR Reagents
PCR Consumables
Other (Software, Pipetting Robot & etc.,)
The period considered for the PCR market analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (France, Germany, United Kingdom, Italy, Spain and Rest of Europe), Asia- Pacific (Japan, China, India, Korea and Rest of Asia-Pacific), Latin America (Brazil, Columbia, Argentina and Rest of Latin America) and Rest of the World. Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.
More than 850 leading market players are identified and 49 key companies that project improved market activities in the near future are profiled. The report consists of 115 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
The broad ‘life science’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the PCR industry, even during the recession years, confirms the positive growth prospects going ahead. Among the major developments in the recent years, gene amplification technology indicates the highest potential growth. Molecular diagnostics and the Human Genome Project (HGP) are two of the main drivers that contribute to the growth of gene amplification technology. It covers all segments such as drug discovery, DNA amplification, forensic identification, gene therapy and diagnosis. Freshly developed PCR Instruments for detecting most of the life threatening diseases also signal positive demand growth. Among the PCR types, q-PCR is expected witness the largest CAGR during 2009-2015.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the PCR industry.
I. REPORT FOCUS
PRODUCT/TOOLS IN PCR
A. INTRODUCTION
DEFINING POLYMERASE CHAIN REACTION
SCOPE OF POLYMERASE CHAIN REACTION
HISTORY OF POLYMERASE CHAIN REACTION
VARIATIONS OF POLYMERASE CHAIN REACTION
ALLELE-PRECISE PCR
PCA (POLYMERASE CYCLING ASSEMBLY) OR ASSEMBLY PCR
ASYMMETRIC PCR
HELICASE-RELIANT AMPLIFICATION
HOT–START PCR
INTERSEQUENCE-SPECIFIC PCR
REVERSE PCR
LIGATION MEDIATED PCR
METHYLATION SPECIFIC PCR
MINIPRIMER PCR
MULTIPLEX LIGATION-RELIANT PROBE AMPLIFICATION
MULTIPLEX PCR
NESTED PCR
OVERLAP-EXTENSION PCR
QUANTITATIVE PCR
RT-PCR
SOLID-PHASE PCR
TAIL-PCR
TOUCHDOWN PCR
PAN-AC
UNIVERSAL FAST WALKING
MERITS & DEMERITS OF POLYMERASE CHAIN REACTION
OPTIMIZING POLYMERASE CHAIN REACTION
THERMAL CYCLERS (POLYMERASE CHAIN REACTION)
PHASES OF POLYMERASE CHAIN REACTION
PARAMETERS FOR SUCCESSFUL PCR
I) METAL ION COFACTORS AND PCR
II) SUBSTRATES AND SUBSTRATE ANALOGS FOR PCR
III) BUFFERS AND SALTS FOR PCR
IV) COSOLVENTS
THERMAL CYCLING CONSIDERATIONS
I) PCR VESSELS
II) TEMPERATURE AND CYCLE TIME OPTIMIZATION
III) PCR AMPLIFICATION CYCLE NUMBER
IV) ENZYME / TARGET
V) HOT START CONDITIONS
THEORY AND METHODOLOGY OF POLYMERASE CHAIN REACTION
METHODOLOGY OF USE
PCR – IMPROVISED TECHNIQUE FOR TESTING NUCLEIC ACIDS
FINAL ELONGATION
POLYMERASE CHAIN REACTION IN CLINICAL DETECTIONS
B. PRODUCT/TOOLS IN POLYMERASE CHAIN REACTION (PCR)
PCR MACHINES
REAL-TIME PCR MACHINES
REAL-TIME PCR INSTRUMENTATION
PCR REAGENTS
ROLE OF PCR REAGENTS
GOTAQ PCR MIX
PRIMERS
NEXT GENERATION PCR REAGENTS FOR CLINICAL DIAGNOSTICS
PCR REAGENT MARKET TRENDS
DNA TEMPLATE
PCR CONSUMABLES
OTHER
PCR SOFTWARE
PCR ROBOTICS
THE AUTOMATION AND USAGE OF ROBOTICS IN AMPLIFICATION ASSAYS
PRE-PCR ROBOTIC SYSTEM
THE POST-PCR ROBOTIC SYSTEM
INTEGRATED ROBOTIC SYSTEM FOR HIGH SAMPLE THROUGHPUT WITHIN A DNA DATABASING UNIT
PCR ARRAYS
NEED OF PCR ARRAYS
DOCTRINE OF ASSAY CORROBORATION FOR NUCLEIC ACID DIAGNOSTIC TESTS
ASSAY CORROBORATION – AN INTRODUCTION
SELECTING AN ASSAY FITTING ITS INTENDED PURPOSE
CONSIDERATIONS TOWARDS PRIMITIVE ASSAY DEVELOPMENTS
A) CARE AND RESTRAINTS
B) PROTECTIONS FOR AVOIDING FALSE-POSITIVE RESULTS
C) SAFEGUARDS FOR AVOIDING NEGATIVE OUTCOMES
D) STANDARDS’ PREPARATION
ASSAY CORROBORATION – PART I
1. REAGENTS’ OPTIMIZATION BESIDES STANDARDIZATION AND ASCERTAINING CRUCIAL CHECKING PARAMETERS
2. REPRODUCIBILITY
3. DIAGNOSTIC PARTICULARITY AND SENSITIVITY DETERMINATION
ASSAY CORROBORATION – PART
1. ASSAY CONDUCT’S PERFORMANCE DETERMINATION
A) ANIMAL POPULATION’S REFERENCE
I) REFERENCE ANIMALS’ NEGATIVITY
II) REFERENCE ANIMALS’ POSITIVITY
III) OTHER ASSAYS’ DETERMINATION OF STATUS OF REFERENCE ANIMALS
2. ENTRY-LEVEL DETERMINATION
ASSAY CORROBORATION – PART
1. STARTING ASSAY REPRODUCIBILITY
ASSAY CORROBORATION – PART
1. CURRICULUM ACCOMPLISHMENT
2. OBSERVING ASSAY FUNCTIONING’S VALIDITY
A) EXPLANATION OF ANALYSES’ RESULTS – ISSUES UPSETTING ASSAY VALIDITY
B) MAINTAINING CORROBORATION CRITERIA
POLYMERASE CHAIN REACTION (PCR) – PRODUCT/TOOLS – GEOGRAPHY MARKET BRIEFING
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
II. MARKET ANALYSIS
POLYMERASE CHAIN REACTION (PCR): PRODUCT/TOOLS – INDUSTRY SNAPSHOT
A. POLYMERASE CHAIN REACTION (PCR): PRODUCT/TOOLS – SEGMENTATION
POLYMERASE CHAIN REACTION (PCR) – GLOBAL
POLYMERASE CHAIN REACTION (PCR) – GEOGRAPHIC REGION
POLYMERASE CHAIN REACTION (PCR) – BY COUNTRY ANALYSIS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
POLYMERASE CHAIN REACTION (PCR) – BY PRODUCT/TOOLS
POLYMERASECHAINREACTION (PCR) – PRODUCT/TOOLS – GEOGRAPHICREGION
PCR MACHINES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
PCR REAGENTS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
PCR CONSUMABLES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
OTHER PCR PRODUCT/TOOLS
NORTH AMERICA
EUROPE
ASIA-PACIFIC
LATIN AMERICA
REST OF WORLD
B. GROWTH RATE ANALYSIS
GLOBAL POLYMERASE CHAIN REACTION (PCR) – MARKET GROWTH RATES
POLYMERASE CHAIN REACTION (PCR) MARKET – PRODUCT/TOOLS
GLOBAL PCR PRODUCT/TOOLS – GROWTH RATES
PCR MACHINES
MARKET GROWTH RATES FOR PCR PRODUCT/TOOLS – PCR MACHINES
PCR REAGENTS
MARKET GROWTH RATES FOR PCR PRODUCT/TOOLS – PCR REAGENTS
PCR CONSUMABLES
MARKET GROWTH RATES FOR PCR PRODUCT/TOOLS – PCR CONSUMABLES
C. INVESTMENT FOCUS
III. INDUSTRY OVERVIEW
A. INDUSTRY ACTIVITIES
MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/INNOVATIONS/PRODUCT LAUNCHES/ETC
THERMO FISHER SCIENTIFIC TO ACQUIRE LIFE TECHNOLOGIES CORPORATION
VEREDUS LABORATORIES APPROVES THE CURRENT VERSION OF VEREFLU
BGI-SHENZHEN ACQUIRES COMPLETE GENOMICS INC.
INIBSA GROUP ACQUIRES BIOTECH BIOTOOLS.
AFFYMETRIX AND DNA LINK SIGN PARTNERSHIP FOR PBA PROGRAM FOR HUMAN IDENTIFICATION
MAST UNVEILS NEW ISOTHERMAL NUCLEIC ACID AMPLIFICATION KITS.
FULL SERVICE OF MICROBIAL DIVERSITY PROFILING IS NOW AVAILABLE.
BIOSEARCH TECHNOLOGIES ANNOUNCES ACQUISITION OF DIVISIONS OF DNA TECHNOLOGY AND VITRABIO.
COUNT YOUR DNA WITH DIGITAL PCR AT TATAA BIOCENTER.
MOBIDIAG’S PROVE-IT BONE&JOINT, A HIGH-QUALITY MULTIPLEXED MOLECULAR DIAGNOSTIC TECHNOLOGY FOR INFECTIOUS DISEASES, ACHIEVES CE-IVD MARKING.
SPOTSTUDIO‘S EARLY ACCESS PROGRAM STARTED.
FULL PD+ SEQUENCING SERVICE IN TUBE FORMATS IS NOW AVAILABLE.
THERMO FISHER SCIENTIFIC LAUNCHES SURETECT PCR SYSTEM FOR FOOD PATHOGEN DETECTION
CELL SIGNALING TECHNOLOGY RECEIVES PATENT FOR PCR METHODS FOR DETECTION OF A SUBSET OF TREATABLE NON-SMALL CELL LUNG CANCERS
BIO-RAD ACQUIRES ABD SEROTEC
THERMO FISHER SCIENTIFIC SHOWCASES INTEGRATED LAB AUTOMATION PORTFOLIO AT SLAS 2013
ILLUMINA ROLLS OUT SEQUENCING TECHNOLOGY INNOVATIONS
TATAA BIOCENTER INTRODUCES QPCR WORKFLOW
TTP LABTECH SHOWCASES ADVANCES IN ASSAY MINIATURIZATION WITH MOSQUITO AT SLAS 2013.
‘FAST PCR’ WITH THE PEQSTAR 2X NOW A REALITY.
AMGEN TO ACQUIRE DECODE GENETICS.
LABOR DIAGNOSTIK LEIPZIG AND QIAGEN JOIN FORCES TO OFFER SOLUTIONS FOR VETERINARY TESTING PORTFOLIO.
SCIENION AND GENOMICA EXPAND COLLABORATION TO PROVIDE A NEW PRINTING TECHNOLOGY FOR MULTIPLE APPLICATIONS.
GENEDATA ANNOUNCED PARTNERSHIP WITH LIFE TECHNOLOGIES CORPORATION.
OCIMUM BIOSOLUTIONS OBTAINS DISTRIBUTION PARTNER FOR SPOLIGOTYPING KITS IN EUROPE.
RAINDANCE TECHNOLOGIES AND INTEGRATED DNA TECHNOLOGIES COLLABORATE TO DEVELOP REAGENTS AND CONSUMABLES FOR DIGITAL PCR
PROMEGA LAUNCHES NEW GOTAQ REAL-TIME PCR SYSTEMS FOR PROBE-BASED DETECTION
TRANSGENOMIC AND NYU COLLABORATE FOR LUNG CANCER STUDY USING ICE COLD-PCR
THERMO FISHER SCIENTIFIC INAUGURATES MOLECULAR BIOLOGY CENTER OF EXCELLENCE IN LITHUANIA
ABBOTT COLLABORATE WITH ASTELLAS PHARMA FOR PHASE 3 CLINICAL TRIAL IN CMV VACCINE.
IDAHO TECHNOLOGY, INC. RENAMED BIOFIRE DIAGNOSTICS, INC. (TM)
SIGMA LIFE SCIENCE ADDS KICQSTART PRIMERS TO ITS QPCR PORTFOLIO
QUINTILES ACQUIRES EXPRESSION ANALYSIS
NEW PRODUCT UPDATE IN AUGUST: THE QPCRSOFT SOFTWARE INCLUDES EVALUATION MODULE “GENOTYPINGâ€.
ADIAGENE ANNOUNCES NEW ADIAVET BESNOITIA REAL TIME PCR KIT.
TAKEDA EXPANDED ITS COLLABORATION WITH GENEDATA.
SOL GROUP ACQUIRES MAJORITY STAKE IN DIATHEVA TO MARK ANOTHER STEP FORWARD IN THE BIOTECH SECTOR.
SACACE BIOTECHNOLOGIES INTRODUCES SACYCLER-96, A NEW REAL TIME PCR SYSTEM.
BECKMAN COULTER, INC. RECEIVES CLIA CERTIFICATE AND MASSACHUSETTS STATE LICENSURE FOR CLINICAL SEQUENCING
INTUITIVE BIOSCIENCES SIGNS AGREEMENT TO ACQUIRE CERTAIN ASSETS OF GENTEL BIOSCIENCES
AFFYMETRIX AND SCREENCELL SIGN AGREEMENT FOR WORLDWIDE DISTRIBUTION OF CTC TECHNOLOGY
VANDALIA RESEARCH RECEIVES U.S. PATENT PROTECTION FOR LARGE-SCALE DNA PRODUCTION TECHNOLOGY
MICROSYNTH AG ANNOUNCES TWO SERVICE IMPROVEMENTS IN THE FIELD OF DNA SANGER SEQUENCING.
INTEGROMICS LAUNCHES OMICSOFFICE, A TOOL THAT FEATURES FUNCTIONAL AND COMPARATIVE APPLICATIONS OFFERING NEW BIOLOGICAL INSIGHTS.
ANALYTIK JENA TO SHOWCASE TECHNOLOGY TRENDS IN THE FIELD OF ANALYTICAL INSTRUMENTATION AND BIOTECHNOLOGY.
INGENUITY SYSTEMS AND LIFE TECHNOLOGIES LAUNCH INGENUITY IREPORT FOR REAL-TIME PCR
QUEST DIAGNOSTICS RECEIVES FDA CLEARANCE FOR SIMPLEXA C. DIFFICILE MOLECULAR TEST
INGENUITY SYSTEMS AND LIFE TECHNOLOGIES LAUNCH INGENUITY IREPORT FOR REAL-TIME PCR
HCV GENOTYPE PLUS REAL-TM, A NEW REAL TIME PCR TEST TO DETERMINE HCV-RNA GENOTYPES.
THERMO FISHER SCIENTIFIC DISPLAYS NEW REAL-TIME PCR SYSTEM
THERMO FISHER SCIENTIFIC RELEASES NEW PERSONAL NANODROP UV-VIS SPECTROPHOTOMETER
ABBOTT TO COLLABORATE WITH GENLAB FOR RAPID MOLECULAR DIAGNOSIS OF SERIOUS ORTHOPEDIC INFECTIONS
CHUGAI PHARMACEUTICAL EXTENDED MULTI-YEAR LICENSING AGREEMENT WITH GENEDATA.
LIFE TECHNOLOGIES INTRODUCES ION AMPLISEQ CUSTOM PANELS FOR UNLOCKING INNUMERABLE DISEASE-RELATED RESEARCH SAMPLES FOR ANALYSIS
ADIAGENE’S PCR DETECTION KIT FOR THE NEWLY IDENTIFIED SCHMALLENBERG VIRUS OBTAINS ANSES VALIDATION.
BECKMAN COULTER TO LAUNCH SPRIWORKS HT, AN AUTOMATIC SAMPLE PREPARATION SYSTEM FOR NEXT-GENERATION SEQUENCING, AT SLAS2012
ABBOTT SIGNS AGREEMENT WITH UNIVERSITY OF NORTH TEXAS SCIENCE CENTER FOR PLEX-ID EVALUATION
LONGGENE ROLLS OUT A300 FAST THERMAL CYCLER
QIAGEN JOINS AMDEC’S VENDOR PARTNERSHIP PROGRAM
BORDETELLA REAL-TM: A REAL TIME PCR KIT FOR DETECTION OF THE BORDETELLA FAMILY OF DISEASES.
EUROPEAN COMMISSION TIGHTENS MEASURES FOR THE IMPORT OF GM RICE FROM CHINA.
IDT LAUNCHES GENOME-WIDE QPCR PRIMERS FOR USE WITH INTERCALATING DYES
XENETIC BIOSCIENCES PLC ANNOUNCES ACQUISITION OF SYMBIOTEC GMBH AND COMPLETION OF ARRANGEMENTS WITH SERUM INSTITUTE OF INDIA.
QUEST DIAGNOSTICS INTRODUCES SIMPLEXA DENGUE TEST IN BRAZIL
IDT EXPANDS ZEN PROBES PORTFOLIO FOR QPCR
PERKINELMER ACQUIRED CALIPER LIFE SCIENCES
TRINEAN AND TATAA BIOCENTER COMMENCE COLLABORATION.
ABBOTT EXPANDS AGREEMENT WITH GSK TO INCLUDE DEVELOPMENT OF A COMPANION DIAGNOSTIC TEST.
SIGMA LIFE SCIENCE UPGRADES OLIGOARCHITECT ONLINE QPCR TOOL
GREINER BIO-ONE’S WHITE PCR MICROPLATES IMPROVE REAL TIME PCR SENSITIVITY.
SENTINELGX PHARMACOGENOMIC AND COMPANION DIAGNOSTIC BLOODRNA SERVICE IS NOW AVAILABLE.
ANALYSIS OF THE USE OF HIGH YIELD BUFFER TO ENHANCE PCRS.
SONY PURCHASES MICRONICS, INC.
GENEWORKS CHAINS THE HUMAN MITOCHONDRIAL TRANSCRIPTOME
EPPENDORF GETS LICENSES TECHNOLOGY FOR THERMAL CYCLERS TO BULLDOG BIO
CALIPER LAUNCHES ZEPHYR NGS POST-PCR WORKSTATION
HKSH SELECTS GE HEALTHCARE’S PET/CT+MR FOR MANAGEMENT OF DISEASES
ABBOTT INTRODUCES ALK GENETIC TEST FOR NSCLC
QIAGEN ACQUIRES CELLESTIS
ABBOTT OBTAINS FDA APPROVAL FOR ALK GENE TEST
BIONEER RELEASES H1N1 VIRUS DIAGNOSTIC KIT
COMPLETE GENOMICS TO SEQUENCE DNA FOR NCI’S PEDIATRIC CANCER STUDY
ABBOTT GETS FDA CLEARANCE FOR VYSIS CLL FISH PROBE KIT
ABBOTT ANNOUNCES SUCCESSFUL TREATMENT OF THE FIRST PATIENT IN JAPAN WITH ABSORB BIORESORBABLE VASCULAR SCAFFOLD
QIAGEN AND PFIZER ANNOUNCE PARTNERSHIP
ABBOTT GETS FDA APPROVAL FOR RX HERCULINK ELITE RENAL STENT SYSTEM
ABBOTT INTRODUCES PLEX-ID VECTOR-BORNE TEST
BIOGEN IDEC AND ABBOTT ANNOUNCE SUCCESS OF SELECT TRIAL FOR RRMS
QIAGEN INAUGURATES TAIWAN SUBSIDIARY IN TAIPEI
QIAGEN COMPLETES SECOND U.S. SUBMISSION FOR THERASCREEN KRAS RGQ PCR KIT
ILLUMINA AND THE UNIVERSITY OF OXFORD COLLABORATE FOR PERSONALIZED MEDICINE
GENOVAC RENAMED ALDEVRON FREIBURG
BD SIGNS AGREEMENT TO ACQUIRE CARMEL PHARMA
STARTING UP THE GENE THERAPY PROJECT IN CHINA
PROMEGAPOWERPLEX 18D SYSTEM OBTAINS NDIS APPROVAL FOR OFFENDER DNA PROFILING
AFFYMETRIX STARTS SHIPMENT OF GENE PROFILING REAGENTS
LIFE TECHNOLOGIES INTRODUCES APPLIED BIOSYSTEMSVETMAXTM-GOLD SIV DETECTION KIT
BIOTAGE INTRODUCES MICROWAVE PEPTIDE SYNTHESIZER
RAISING THE BAR IN MICROWAVE SYNTHESIS BY BIOTAGE
GRIFOLS COMPLETES ACQUISITION OF TALECRIS AND ANNOUNCES LISTING OF ITS ADSS ON NASDAQ
COMPLETE GENOMICS INTRODUCES CANCER GRANT PROGRAM
PROMEGA INTRODUCES BIOLUMINESCENT HDAC ASSAYS
QIAGEN PREPARES PROPOSAL TO FULLY ACQUIRE IPSOGEN
ENZOBIOCHEM SIGNS AGREEMENT WITH INCELLDX AGREE TO MARKET HPV ONCOTECT TEST
EUROFINSMEDIGENOMIX’S NEW SERVICE FOR TESTING OF DNA CONTAMINATION
NEW SOFTWARE SPEEDS VALIDATION OF AUTOMATED LIQUID HANDLING PROCESSES
ABBOTT OBTAINS CE MARK FOR ITS REAL TIME PCR TEST FOR CMV
BD DIAGNOSTICS LAUNCHES BD MAX IN THE U.S.
LABSCO SET TO DISTRIBUTE CEPHEID’S GENEXPERT� SYSTEMS
ABBOTT GETS FDA APPROVAL FOR MOLECULAR TEST FOR HEPATITIS C
AGILENT ANNOUNCES 2011 MANFRED DONIKE AWARD FOR EXCELLENCE IN SPORTS-DOPING DETECTION
ROCHE DIAGNOSTICS LAUNCHES ITS NEW BLOOD GAS ANALYZER
ROCHE DIAGNOSTICS LAUNCHES THE COBAS 8000 MODULAR ANALYZER
LIFE TECHNOLOGIES INTRODUCES 7500 FAST DX REAL-TIME PCR INSTRUMENT AND 3500 DX SERIES GENETIC ANALYZER IN JAPAN
AFFYMETRIX, FIRST IN THE INDUSTRY TO ACHIEVE FDA CLEARANCE FOR MICROARRAY-BASED GENE EXPRESSION REAGENTS
CALIPER ANNOUNCES RESEARCH COLLABORATION WITH CHI
AFFYMETRIX LAUNCHES SECOND GENERATION ONCOSCAN FFPE EXPRESS 2.0
AGILENT TECHNOLOGIES LAUNCHES AGILENT SURECYCLER 8800
INSTEM ACQUIRES BIOWISDOM
LIFE TECHNOLOGIES FORTIFIES ITS DNA SEQUENCING PLATFORM
GENSCRIPT LAUNCHES GANP TECH SERVICES GLOBALLY EXCLUDING JAPAN
ABBOTT RECEIVES CE MARK FOR NEW PCR-BASED HIV-1 TEST
QIAGEN RECEIVES SFDA APPROVAL FOR CARE HCV RT-PCR KIT V2
BD ACQUIRES ACCURI CYTOMETERS
AFFYMETRIX INTRODUCES SNP CORE REAGENT KIT FOR SNP ARRAY 6.0 CUSTOMERS
CALIPERS AND HISTORX JOINT VENTURE FOR TISSUE-BASED INTEGRATED SOLUTIONS FOR PROTEIN QUANTIFICATION OF BIOMARKERS
CYTOCELL DEVELOPS NEW FGFR1 FISH PROBE
AFFYMETRIX UNVEILS NEXT-GENERATION MICRORNA SOLUTION
INTEGENX AND CALIPER SIGN LICENSE AGREEMENT
CYTOCELL STARTS DISTRIBUTION IN BULGARIA
TAKARA BIO ESTABLISHES A SUBSIDIARY
GENE LOGIC INTRODUCES ASCENTA 4.0 WITH SUPERIOR FUNCTIONALITY
PROMEGA AND FUGENT LLC SIGN AGREEMENT FOR SUPPLY OF FUGENE
ABBOTT’S IBIS TECHNOLOGY TO IDENTIFY ORGANISM CAUSING PLAGUE IN AFGHANISTAN
ABBOTT PRESENTS THE PLEX-ID BIOTHREAT ASSAY
CYTOCELL LAUNCHES FIVE NEW T-CELL ALL FISH PROBES
PROMEGA LAUNCHES RELIAPREP BLOOD AND TISSUE GDNAMINIPREP SYSTEMS
LIFE TECHNOLOGIES LAUNCHES PCR DETECTION KIT FOR SALMONELLA ENTERITIDIS IN POULTRY EGGS
AFFYMETRIX LAUNCHES THE AXIOM(TM) GENOME-WIDE BOS 1 ARRAY FOR BOVINE GENOTYPING
ILLUMINA ACQUIRES EPICENTRE BIOTECHNOLOGIES
ILLUMINA AFFIRMS MISEQ(TM) PERSONAL SEQUENCING SYSTEM’S ADVANTAGES
ILLUMINA INTRODUCES NEXT GENERATION OF ISELECT(R) CUSTOM GENOTYPING PRODUCTS
BIOSPECTRUM HONORS OCIMUM BIOSOLUTIONS AS THE BEST BIOINFORMATICS COMPANY
CALIPER ACQUIRES CRI
CMB AND BIO RAD PARTNER TO DEVELOP DNA BARCODING INSTRUCTIONAL ACTIVITIES
SPARTAN RX CYP2C19 RECEIVES CE MARKING
OCIMUM CLOSES $8 MILLION TO FUEL FUTURE GROWTH
CALIPER SIGNS AGREEMENT TO ACQUIRE CRI
AGILENT AND UC DAVIS COLLABORATE FOR FOOD SAFETY RESEARCH
LIFE TECHNOLOGIES LAUNCHES APPLIED BIOSYSTEMSVETMAX-GOLD BVDV DETECTION KIT
ONLINE QUOTATION SYSTEM FOR POLYCLONAL ANTIBODY SERVICE BY GENSCRIPT
IMMUNOLOGIX TEAMS WITH GENSCRIPT
ILLUMINA INTRODUCES TRUSEQ(TM) SAMPLE PREP AND EXOME ENRICHMENT KITS
ADDITION OF GENE EDITING TECHNOLOGY
AXIOM ANALYTICAL’S ACCURATE TEMPERATURE CONTROL WITH FIBER-OPTIC
QIAGEN LAUNCHED STANDARDIZED SOLUTIONS FOR MOLECULAR ANALYSIS OF FFPE SAMPLES
ILLUMINA ANNOUNCES HISEQ 1000 SEQUENCING SYSTEM
TAKARA BIO GETS ANTI-CANCER DRUG
FDA CONSENTS ROCHE’S REAL-TIME PCR COBAS TAQMAN HCV TEST, V2.0
B. MARKET TRENDS
SPARTAN BIOSCIENCE DX-12 DNA ANALYZER – A BOON TO BIOTECHNOLOGY
REDDYMIX – A BUFFER FOR PCR REAGENTS
NEXT GENERATION PCR APPROVES EVOLUTION POLYMERASES
QUICKPROBE(TM) QPCR- A BONUS TO LIFE SCIENCES COMPANIES
MASTER CLEAR CAP STRIPS – AN ADDITION TO PCR CONSUMABLES
DIGITAL PCR TECHNOLOGY BY FLUIDIGM
GREENECHIP TECHNOLOGY- UNPREJUDICED PATHOGEN DISCOVERY
INCREASING DEMAND FOR QRT-PCR PRODUCTS
QIAGEN’S NEW SOLUTION TO ACCELERATE PCR
OPTO TECHNOLOGY’S NEW INVENTION – OTHP-0050
TIE UP BETWEEN FISHER BIOSCIENCES AND APPLIED BIOSYSTEMS
FISHER BIOSCIENCES AND DYOMICS MERGE FOR BETTERMENT
PCR MACHINES – IMPACT ON LIFE SCIENCES EQUIPMENT.
C. INDUSTRY LEADERS
ABBOTT LABORATORIES (USA)
AGILENT TECHNOLOGIES INC (USA)
BIONEER INC (USA)
COMPLETE GENOMICS, INC. (USA)
EPICENTRE BIOTECHNOLOGIES (USA)
GENISPHERE INC. (USA)
MAXIM BIOTECH, INC (USA)
OCIMUM BIOSOLUTIONS LTD.
QIAGEN INC (USA)
SACACE BIOTECHNOLOGIES S.R.L. (ITALY)
TAKARA BIO, INC.
THERMO FISHER SCIENTIFIC, INC.
LIGHTUP TECHNOLOGIES AB (SWEDEN)
HY LABORATORIES LTD. (ISRAEL)
D. POLYMERASE CHAIN REACTION (PCR) – A LOOK A HEAD..!!
E. KEY COMPANY PROFILES
NORTH AMERICA
EUROPE
ASIA-PACIFIC
REST OF WORLD
F. POLYMERASE CHAIN REACTION (PCR) – PATENTS
PCR PATENT EXPIRY AND ITS EFFECT ON MARKET STRATEGIES
EXPIRY OF PCR PATENT OFFERS EXCITING GROWTH OPPORTUNITIES FOR NUCLEIC ACID PURIFICATION
AND AMPLIFICATION TECHNOLOGIES
INNOVATIVE FEATURES WIDEN APPLICATION BASE AND BOOST REVENUE
PATENT EXPIRATION
MOLECULAR DIAGNOSTICS UNCHAINED
THE POLYMERASE CHAIN REACTION PATENT ENDING: AN EXPIRING PATENT MARKS THE END OF A BIOTECHNOLOGICAL ERA
EXPIRING PATENTS, UPTICK IN BIOTECH SPENDING COULD SPUR QPCR-BASED DX, TOOL DEVELOPMENT
THE POLYMERASE CHAIN REACTION PATENTS: GOING, GOING,… STILL GOING
THE POST-PATENT OPPORTUNITY
PATENT WARS
PCR – A PATENT THAT REVOLUTIONIZED BIOTECHNOLOGY AND LAUNCHED A TV SERIES
PATENT RULING COULD CUT PCR ENZYME PRICES
PCR PATENT ISSUES
1. INTRODUCTION
2. INTELLECTUAL PROPERTY RIGHTS
3. NAVIGATING THE PCR PATENT MINEFIELD
3.1. OBTAINING RIGHTS TO PRACTICE PCR
3.2. BONA-FIDE RESEARCHERS ARE NOT INFRINGERS
3.3. NOT EVERY PATENT IS A VALID PATENT
IV. INDUSTRY COMPANY DATABASE
V. APPENDIX
A. RESEARCH FOCUS
B. ABOUT AXIS RESEARCH MIND
C. DISCLAIMER
D. FEEDBACK
